• Hyoscyamine Sulfate Recall

    On September 16, 2016 the U.S. Food and Drug Administration (FDA) released a product recall to the wholesale and retail level, including hospitals and pharmacies. The recall involves Hyoscyamine sulfate (0.125mg) manufactured by Virtus Pharmaceuticals Opco II, LLC (Virtus). Virtus Pharmaceuticals is voluntarily recalling seven batches of Hyoscyamine sulfate (0.125mg). Virtus Pharmaceuticals is working as…

    Read More...
  • GlucaGen HypoKit Recall

    On September 9th, 2016 the U.S. Food and Drug Administration (FDA) released a product recall to the wholesale and retail level, including hospitals and pharmacies. The recall involves GlucaGen HypoKit (glucagon [rDNA origin] for injection) manufactured by Novo Nordisk Inc. Novo Nordisk Inc. is recalling six batches of the GlucaGen HypoKit in the U.S. due…

    Read More...
  • Opioid Prescribing Limits – Effective October 1, 2016

    Opioid Prescribing Limits – Effective October 1, 2016 Managed Health Services (MHS) is implementing new prescribing limits for opioid medications. The limits are in response to the opioid epidemic that is sweeping our nation. MHS has worked with the State Medicaid program to determine a set of common criteria that balances the clinical need for…

    Read More...
More News